Articles from DIA

ZUG, SWITZERLAND / ACCESS Newswire / November 5, 2026 / DIA, the trustless blockchain oracle network, today published "The New Stablecoin Fragmentation," a large study of 140+ active stablecoins from nearly 100 issuers in 25 currencies, built on DIA's Global Stablecoin Map, a public dashboard. It finds euro stablecoins added $263 million in the year to 19 October, up 54%, while dollar stablecoin supply fell 1.3%. At $790 million, the euro is now the largest non-dollar stablecoin market.

DIA, a global non-profit organization of life sciences professionals, will induct four Fellows of DIA and recognize six recipients of Global Inspire Awards and America’s Inspire Awards on June 15 as part of the DIA 2025 Global Annual Meeting — including Emer Cooke, Executive Director of the European Medicines Agency (EMA), who is receiving both honors.

DIA, a global non-profit organization of life sciences professionals, will convene the world’s leading regulators, researchers, and innovators from nearly 50 countries at the DIA 2025 Global Annual Meeting, held June 15–19 in Washington. As the life sciences industry confronts rapid scientific advances and shifting global health policies, the Global Annual Meeting offers an opportunity for stakeholders to align in real time on regulation, innovation, and global access.

DIA, a global non-profit organization of life sciences professionals, will unite thousands of stakeholders to address the future of international regulatory cooperation during the DIA 2025 Global Annual Meeting from June 15-19 in Washington. As policy shifts and regulatory relationships grow more uncertain, DIA 2025 gives the global life sciences community a place to confront these changes as they're unfolding.

DIA, a global multidisciplinary life sciences membership association, will bring together thousands of stakeholders from all over the world to address opportunities for collaboration in medical product development to advance innovations and improve patient outcomes. The DIA 2025 Global Annual Meeting (DIA 2025) will take place June 15-19 in Washington, DC, at a crucial time for cross-border collaboration in health and life sciences as technological and clinical innovations, regulatory developments, and health policy shifts reshape partnerships worldwide.

DIA, a global non-profit organization of life sciences professionals, will examine the integration of artificial intelligence (AI) in safety workflows and the impact of real-world evidence (RWE) during its annual Global Pharmacovigilance and Risk Management Strategies Conference, which will be held from Jan. 27 to Jan. 29 in Baltimore.

DIA, a global organization of life sciences professionals, will showcase demonstrations from inventor Dean Kamen and his science and technology organizations during the DIA 2024 Global Annual Meeting from June 16-20 in San Diego.

DIA, a global organization of life sciences professionals, will feature the patient perspectives of Emily and Tom Whitehead and insights from inventor Dean Kamen during keynote addresses at the DIA 2024 Global Annual Meeting, to be held June 16-20 in San Diego.

The ethical use of artificial intelligence (AI) in healthcare, the development of advanced therapies, and other emerging regulatory and scientific challenges demand in-depth discussion as DIA, a global organization of life sciences professionals, accepts registrations for the DIA 2024 Global Annual Meeting, to be held June 16-20 in San Diego.

DIA, a global organization of life science professionals, and the Tufts Center for the Study of Drug Development (Tufts CSDD) have come together to conduct a study that furthers the understanding of how artificial intelligence (AI) supports the continuum of drug development.

Today, at the DIA (Drug Information Association) Global Annual Meeting in Boston, MA, the organization welcomed fresh faces to their multidisciplinary Board of Directors and expressed gratitude to the outgoing Directors for their many contributions.

DIA, the premier professional global community for healthcare product development, will host its 2023 Global Annual Meeting in Boston, June 25-29. In keeping with this year's theme, “Illuminate,” the event underscores the importance of convening global sponsors, CROs, regulators, academics, and patients face-to-face for honest and open collaboration that illuminates the path to the future of healthcare and ignites critical change in drug, device, and diagnostic development.

DIA, founded as the Drug Information Association, announced today that it has named Marwan Fathallah as President and Global Chief Executive. Mr. Fathallah will lead the organization to help drive thought leadership and innovation in therapeutic development to improve the health of people worldwide.

The Drug Information Association (DIA) today announced that Barbara Lopez Kunz will step down from her position as DIA President and Global Chief Executive at the end of the year after over nine years of serving in this role. In addition to effectively navigating the organization through the unprecedented challenges of a global pandemic, she has led the organization as it strengthened its relevance, transformed its strategy and governance model, built a sustainable business infrastructure, and launched new impactful initiatives benefiting members around the globe.

DIA, the premier professional global community for healthcare product development, will host its in-person Global Annual Meeting in Chicago on June 19-23. This event marks the first time since 2019 that the association has convened global industry, regulators, academics, and patients together face-to-face with a goal of exploring and discussing some of the life science industry’s most pressing challenges and opportunities.

DIA is aiding the emergence of the metaverse by creating the tools to connect NFT ecosystems with Decentralised Finance, using data and NFTs. ZUG, SWITZERLAND / ACCESSWIRE / September 7, 2021 / DIA Association has launched data provision services for the fast growing NFT ecosystem, as a way to connect the explosive growth of defi to the metaverse - a collective virtual shared space, the vision of which is leading growth in VR, AR, AI and